Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 4CzIPN. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120965536A enables mild photoredox synthesis. Offers supply chain reliability and cost reduction for high-purity pharmaceutical intermediates manufacturing.
Novel visible-light method using 4CzIPN for high-purity sulfone intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN110963900A details a metal-free oxidative decarboxylation method using 4CzIPN and air, offering a green route for high-purity pharmaceutical intermediates manufacturing.
Patent CN116462636B reveals green visible light synthesis for quinoxalinone derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115232159A reveals a novel photoredox C-H borylation method. Enables cost reduction in pharmaceutical intermediate manufacturing with high regioselectivity.
Patent CN114805209A details a metal-free photocatalytic route for 3-aryl-2H-indazoles using aryl sulfonium salts, offering cost reduction and supply chain reliability.